Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development, commercialization, and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, engineering, and cell processing to produce active cellular immunotherapy (ACI) product candidates designed to stimulate an immune response in a variety of tumor types.


Publications show all

Dendreon has published 35 articles.

Patents show all


Clinical Trials show all

13Phase 25N/A4Phase 32Phase 1

SEC Filings show all


Contact Information